FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092332 [Registered on: 04/08/2025] Trial Registered Prospectively
Last Modified On: 04/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study on the Link Between Breathing problems and urine leakage in people with lung disease 
Scientific Title of Study   ASSOCIATION BETWEEN LUNG FUNCTION PEAK EXPIRATORY FLOW RATE PEFR AND URINARY INCONTINENCE IN INDIVIDUALS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD  
Trial Acronym  Lung function Incontinence Pefr in COPD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ranjana Manjunatha Hegde 
Designation  Postgraduate Student 
Affiliation  SDM College Of Physiotherapy Dharwad 
Address  SDM College Of Physiotherapy Shri Dharmasthala Manjunatheshwara University Dharwad 580009 Karnataka

Dharwad
KARNATAKA
580009
India 
Phone  9481572387  
Fax    
Email  hegderanjanamanjunath@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shubha Akadas 
Designation  Assistant Professor 
Affiliation  SDM College Of Physiotherapy Dharwad 
Address  SDM College Of Physiotherapy Shri Dharmasthala Manjunatheshwara University Dharwad 580009 Karnataka

Dharwad
KARNATAKA
580009
India 
Phone  9739488007  
Fax    
Email  shubhaakadas@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shubha Akadas 
Designation  Assistant Professor 
Affiliation  SDM College Of Physiotherapy Dharwad 
Address  SDM College Of Physiotherapy Shri Dharmasthala Manjunatheshwara University Dharwad 580009 Karnataka

Dharwad
KARNATAKA
580009
India 
Phone  9739488007  
Fax    
Email  shubhaakadas@gmail.com  
 
Source of Monetary or Material Support  
SDM College Of Medical Sciences And Hospital Dharwad 
 
Primary Sponsor  
Name  Ranjana Manjunatha Hegde 
Address  SDM College of Physiotherapy Shri Dharmasthala Manjunatheshwara University Dharwad 580009 Karnataka 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ranjana Manjunatha Hegde  SDM College Of Medical Sciences And Hospital Dharwad  COPD Diagnosed Patients in Pulmonology OPD And IPD SDM College Of Medical Sciences And Hospital Manjushree Nagar Sattur Dharwad 580009
Dharwad
KARNATAKA 
9481572387

hegderanjanamanjunath@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC SDM College of Medical Sciences And Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J96-J99||Other diseases of the respiratory system, (2) ICD-10 Condition: N30-N39||Other diseases of the urinary system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1 Individuals willing to participate
2 Individuals diagnosed with COPD by
pulmonologist and aged in between 40 75 yrs
3 Individuals of all genders
4 Individuals who can read or write and communicate in English hindi or kannada
5 COPD individuals with co morbid conditions under control like Hypertension and diabetes
 
 
ExclusionCriteria 
Details  1 Patients who are on supplemental oxygen or artificial ventilation
2 Patients unable to follow commands
3 Individuals with recent MI or unstable angina
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
ICIQ UI SF questionnaire
FEV1 TO FVC ratio
PEFR AND MVV
 
First day  
 
Secondary Outcome  
Outcome  TimePoints 
MMRC Breathleness grade
Leicester Cough Questionnaire 
First day 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [hegderanjanamanjunath@gmail.com].

  6. For how long will this data be available start date provided 14-07-2027 and end date provided 14-07-2030?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Participants diagnosed with COPD by pulmonologist will be selected based on inclusion and exclusion criteria Individuals who are willing to participate an informed consent form will be given and included in the study  These participants will be assessed for Urinary Incontinence using ICIQ-UI SF International Consultation on Incontinennce Questionnaire Urinary Incontinence Short Form and Pulmonary function tests FEV1 to FVC ratio peak expiratory flow rate PEFR and MVV will be conducted to evaluate lung function Cough severity will be assessed by the Leicester Cough Questionnaire and breathlessness will be assessed by the modified Medical Research Council mMRC grading scale

The PFT FEV1 to FVC ratio PEFR and MVV results of participants with both COPD and UI will then be compared to those of participants with COPD alone 
Close